Clinical Trial Update: Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing acceptability of a new flavor system with increasing mannitol levels for PEG 3350 in adults with constipation; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• PEG 3350 (polyethylene glycol 3350)

Snippet

Sponsor: Bayer | Conditions: Constipation | Phase 4 | Status: COMPLETED | Results posted: 2020-11-12